Bovine Mastitis Treatment Market Size, Share, Growth 2031

Report Code : CVMI170520252 | Published Date : May 17, 2025

The Bovine Mastitis Treatment Market is one of the most critical sectors in dairy health management. Mastitis, an inflammation of the mammary gland, represents the costliest disease affecting dairy cattle globally, leading to reduced milk yield, inferior milk quality, and premature culling. In 2024, the global market for bovine mastitis treatment is valued at USD 1.92 billion, and it is projected to reach USD 2.95 billion by 2031, growing at a CAGR of 6.3%. Demand for effective diagnostics, antibiotic alternatives, and preventive solutions is rising as producers aim to comply with antibiotic stewardship regulations and minimize economic losses.

Key Market Drivers

1. High Economic Burden of Mastitis: Each clinical case may cost a dairy farm up to USD 400–500 due to lost production, treatment costs, and discarded milk.

2. Antibiotic Usage Regulations: Increasing restrictions on antibiotic usage, particularly in Europe and North America, are pushing demand for selective dry cow therapy and non-antibiotic alternatives.

3. Adoption of Preventive Protocols: Focus is shifting toward hygiene-based interventions, immune boosters, and teat sealants to reduce the incidence of mastitis at the herd level.

4. Rapid Diagnostic Advancements: On-farm diagnostic tools are helping in early detection and selective treatment, improving cure rates and reducing overuse of antimicrobials.

Market Segmentation

By Product Type

Antibiotics (45%) – Intramammary and systemic formulations
Teat Sealants (XX%) – Internal and external
Anti-inflammatories (XX%) – NSAIDs and steroidal options
Diagnostic Kits (XX%) – Culture-based and PCR tools
Probiotics and Immune Enhancers (XX%) – Preventive and recovery aids

By Type of Mastitis

Clinical Mastitis (XX%)
Subclinical Mastitis (XX%)

By Route of Administration

Intramammary (50%)
Injectable (XX%)
Oral and Feed-Based (XX%)
Topical/External (XX%)

By Region

North America (30%)
Europe (XX%)
Asia-Pacific (XX%)
Latin America and Others (XX%)

Competitive Landscape

Veterinary pharma leaders are introducing targeted, residue-safe, and fast-acting mastitis therapeutics:

Zoetis – Orbeseal® and Spectramast® lines for mastitis prevention and cure
Boehringer Ingelheim – Ubrolexin® and antibiotic-free mastitis protocols
Elanco Animal Health – Mastitis therapies integrated with dairy welfare programs
MSD Animal Health – Innovation in selective dry cow therapy and intramammary delivery systems

Emerging Trends

1. Selective Dry Cow Therapy (SDCT): Guided by on-farm diagnostics, SDCT reduces antibiotic use while maintaining udder health.

2. Non-Antibiotic Mastitis Control: Teat sealants, probiotics, and immune stimulants are gaining popularity as preventive tools.

3. On-Farm PCR Diagnostics: Rapid cow-side tests now allow detection of mastitis-causing pathogens within hours.

4. Sensor-Based Monitoring: Wearables and milking robots are helping identify mastitis by monitoring temperature, milk conductivity, and behavior.

Regulatory Landscape

In Europe, intramammary antibiotic use is now limited to culture-confirmed cases. The U.S. and Canada promote SDCT through national guidelines. India, Brazil, and other major producers are rolling out mastitis control programs and withdrawal-period enforcement to meet global residue standards.

Reasons To Buy

Scope

Zoetis Inc.
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Ceva Santé Animale
DeLaval
Norbrook Laboratories Ltd.
ImmuCell Corporation
Advanced Animal Diagnostics
HIPRA

Bovine Mastitis Treatment Market Report

1. Bovine Mastitis Treatment Market Research Report

2. Bovine Mastitis Treatment Market Research Report - Preface

3. Bovine Mastitis Treatment Market Dynamics

4. Bovine Mastitis Treatment Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031

5. Bovine Mastitis Treatment Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)

6. Bovine Mastitis Treatment Market, By Type of Mastitis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)

7. Bovine Mastitis Treatment Market, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)

8. Bovine Mastitis Treatment Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)

9. North America Bovine Mastitis Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)

10. Europe Bovine Mastitis Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)

11. Asia-Pacific Bovine Mastitis Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)

12. Latin America Bovine Mastitis Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)

13. Middle East and Africa Bovine Mastitis Treatment Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)

14. Competition Landscape

15. Data Collection Method and Research Approach

16. Principal Presumptions and Acronyms